Ambry Genetics and RainDance Technologies Announce Partnership for Diagnostics and Genomics Services

Ambry Genetics and RainDance Technologies have jointly announced their partnership, utilizing the RDT 1000 for sequence enrichment and resequencing validation.

A provider of genetic testing and next generation sequencing services, Ambry Genetics is a Clinical Laboratory Improvement Amendments (CLIA) certified and College of American Pathologists (CAP) accredited Diagnostic and Genomic Services company providing solutions to both clinical and research clients.

Researchers can utilize the RDT 1000 and Ambry Genetics Next Generation Services to either reduce study time, or to improve study quality by running more samples in the same time within the same experimental budget.